Your browser is out of date. It has known security flaws and may not display all features of this and other websites.
Learn how to update your browser.
Faculty News
7/18/2019 8:17:29 AM
Time to Reset International Banking Relationships
Prof. James Cooper

In a recent op-ed in The Hill, California Western’s Professor James Cooper discusses the need for the IMF and World Bank to work on updating their respective missions.

Learn More
Faculty News
7/9/2019 10:09:58 AM
AIs Impact on Patent Prosecution
Prof. Tabrez Ebrahim

In a recent scholarly paper presented at the 2019 Georgia State University Law Review Symposium, California Western’s Professor Tabrez Ebrahim discussed the impact artificial intelligence (AI) is having on patent prosecution, specifically caused by automation and predictive analytics.

Learn More
Faculty News
6/13/2019 8:42:41 AM
The Struggle Over the Soul of Contract Law
Professor Nancy Kim

In a recent article published in the Jurist, California Western’s Professor Nancy Kim discusses the American Law Institute proposed Restatement of the Law of Consumer Contracts (RLCC) which continues to be the subject of thoughtful and energetic discussion by contracts law professors who care about making sure that the next generation of lawyers gets the law right.

Learn More
Faculty News
5/28/2019 8:46:00 AM
Is NAFTA’s Replacement Doomed?
Prof. James Cooper

In a recent op-ed in The Hill, California Western’s Professor James Cooper argues that the replacement for NAFTA may not bring the economic gains touted by the Trump administration and that the new deal is potentially dead in the water.

Learn More
Faculty News
5/21/2019 9:01:07 AM
Closing the Gap Between Consumer Perceptions of Risk and Evidence-based Assessment of Risk
Prof. Joanna Sax

California Western’s E. Donald Shapiro Professor of Law Joanna Sax talks about her recent scholarly research, Ambiguity and Consumer Perceptions of Risk in Various Areas of Biotechnology, which addresses understanding why consumers assign a high risk to various forms of biotechnology when the evidence-based assessment of risk is low.

Learn More